| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 647117 | Null | 0.00526022686151165 | 0.42443227 |
| NSC 649307 | Null | 0.00526022686151165 | 0.23032759 |
| NSC 659949 | 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone | 0.00526022686151165 | 0.28601274 |
| NSC 665759 | Null | 0.00526022686151165 | 0.074795484 |
| NSC 670664 | Null | 0.00526022686151165 | 0.39870241 |
| NSC 672215 | Null | 0.00526022686151168 | 0.34175285 |
| NSC 678355 | L-LYS-L-p-NO2Phe-L-Ala-L-p-NO2PheNH2 | 0.00526022686151168 | 0.32642642 |
| NSC 679001 | 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- | 0.00526022686151168 | 0.12055769 |
| NSC 682011 | Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- | 0.00526022686151168 | 0.23759689 |
| NSC 690270 | ANTINEOPLASTIC-690270 | 0.00526022686151168 | 0.25575347 |